These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
191 related articles for article (PubMed ID: 9875139)
1. Pancreatic endocrine tumours: evidence for a tumour suppressor pathogenesis and for a tumour suppressor gene on chromosome 17p. Beghelli S; Pelosi G; Zamboni G; Falconi M; Iacono C; Bordi C; Scarpa A J Pathol; 1998 Sep; 186(1):41-50. PubMed ID: 9875139 [TBL] [Abstract][Full Text] [Related]
2. Detailed deletion mapping in sporadic breast cancer at chromosomal region 17p13 distal to the TP53 gene: association with clinicopathological parameters. Seitz S; Poppe K; Fischer J; Nothnagel A; Estévez-Schwarz L; Haensch W; Schlag PM; Scherneck S J Pathol; 2001 Jul; 194(3):318-26. PubMed ID: 11439364 [TBL] [Abstract][Full Text] [Related]
3. Frequent p53 gene mutations in serrated adenomas of the colorectum. Hiyama T; Yokozaki H; Shimamoto F; Haruma K; Yasui W; Kajiyama G; Tahara E J Pathol; 1998 Oct; 186(2):131-9. PubMed ID: 9924427 [TBL] [Abstract][Full Text] [Related]
4. Loss of heterozygosity of a locus on 17p13.3, independent of p53, is associated with higher grades of astrocytic tumours. Chattopadhyay P; Rathore A; Mathur M; Sarkar C; Mahapatra AK; Sinha S Oncogene; 1997 Aug; 15(7):871-4. PubMed ID: 9266974 [TBL] [Abstract][Full Text] [Related]
6. Multiple target sites of allelic imbalance on chromosome 17 in Barrett's oesophageal cancer. Dunn J; Garde J; Dolan K; Gosney JR; Sutton R; Meltzer SJ; Field JK Oncogene; 1999 Jan; 18(4):987-93. PubMed ID: 10023674 [TBL] [Abstract][Full Text] [Related]
7. Somatic TP53 mutations are relatively rare among adrenocortical cancers with the frequent 17p13 loss of heterozygosity. Libè R; Groussin L; Tissier F; Elie C; René-Corail F; Fratticci A; Jullian E; Beck-Peccoz P; Bertagna X; Gicquel C; Bertherat J Clin Cancer Res; 2007 Feb; 13(3):844-50. PubMed ID: 17289876 [TBL] [Abstract][Full Text] [Related]
8. A comparison of the genetic pathways involved in the pathogenesis of three types of colorectal cancer. Tomlinson I; Ilyas M; Johnson V; Davies A; Clark G; Talbot I; Bodmer W J Pathol; 1998 Feb; 184(2):148-52. PubMed ID: 9602705 [TBL] [Abstract][Full Text] [Related]
9. Molecular genetic studies in medulloblastomas: evidence for tumor suppressor genes at the chromosomal regions 1q31-32 and 17p13. Pietsch T; Koch A; Wiestler OD Klin Padiatr; 1997; 209(4):150-5. PubMed ID: 9293446 [TBL] [Abstract][Full Text] [Related]
10. Mutational analyses of WNT7A and HDAC11 as candidate tumour suppressor genes in sporadic malignant pancreatic endocrine tumours. Lindberg D; Akerström G; Westin G Clin Endocrinol (Oxf); 2007 Jan; 66(1):110-4. PubMed ID: 17201809 [TBL] [Abstract][Full Text] [Related]
11. High incidence of loss of heterozygosity at chromosome 17p13 in breast tumours from BRCA2 mutation carriers. Eiriksdottir G; Barkardottir RB; Agnarsson BA; Johannesdottir G; Olafsdottir K; Egilsson V; Ingvarsson S Oncogene; 1998 Jan; 16(1):21-6. PubMed ID: 9467939 [TBL] [Abstract][Full Text] [Related]
12. Loss of heterozygosity at 17p13.3-ter, distal to TP53, correlates with negative hormonal phenotype in sporadic breast cancer. Roncuzzi L; Brognara I; Baiocchi D; Amadori D; Gasperi-Campani A Oncol Rep; 2005 Aug; 14(2):471-4. PubMed ID: 16012732 [TBL] [Abstract][Full Text] [Related]
13. Mutation at chromosome 11q23 in human non-familial breast cancer: a microdissection microsatellite analysis. Koreth J; Bethwaite PB; McGee JO J Pathol; 1995 May; 176(1):11-8. PubMed ID: 7616353 [TBL] [Abstract][Full Text] [Related]
14. Molecular analysis of the lissencephaly gene 1 (LIS-1) in medulloblastomas. Koch A; Tonn J; Kraus JA; Sorensen N; Albrecht NS; Wiestler OD; Pietsch T Neuropathol Appl Neurobiol; 1996 Jun; 22(3):233-42. PubMed ID: 8804025 [TBL] [Abstract][Full Text] [Related]
15. Loss of heterozygosity is detected at chromosomes 1p35-36 (NB), 3p25 (VHL), 16p13 (TSC2/PKD1), and 17p13 (TP53) in microdissected apocrine carcinomas of the breast. Lininger RA; Zhuang Z; Man Y; Park WS; Emmert-Buck M; Tavassoli FA Mod Pathol; 1999 Dec; 12(12):1083-9. PubMed ID: 10619258 [TBL] [Abstract][Full Text] [Related]
16. Microsatellite instability and somatic mutations in endometrial carcinomas. Sakamoto T; Murase T; Urushibata H; Kato K; Takada H; Imamura T; Mori H; Wake N Gynecol Oncol; 1998 Oct; 71(1):53-8. PubMed ID: 9784319 [TBL] [Abstract][Full Text] [Related]
17. Chromosomal instability rather than p53 mutation is associated with response to neoadjuvant cisplatin-based chemotherapy in gastric carcinoma. Ott K; Vogelsang H; Mueller J; Becker K; Müller M; Fink U; Siewert JR; Höfler H; Keller G Clin Cancer Res; 2003 Jun; 9(6):2307-15. PubMed ID: 12796400 [TBL] [Abstract][Full Text] [Related]
18. Detailed deletion mapping suggests the involvement of a tumor suppressor gene at 17p13.3, distal to p53, in the pathogenesis of lung cancers. Konishi H; Takahashi T; Kozaki K; Yatabe Y; Mitsudomi T; Fujii Y; Sugiura T; Matsuda H; Takahashi T; Takahashi T Oncogene; 1998 Oct; 17(16):2095-100. PubMed ID: 9798680 [TBL] [Abstract][Full Text] [Related]
19. 3p21, 5q21, and 9p21 allelic deletions are frequently found in normal bronchial cells adjacent to non-small-cell lung cancer, while they are unusual in patients with no evidence of malignancy. Sanz-Ortega J; Saez MC; Sierra E; Torres A; Balibrea JL; Hernando F; Sanz-Esponera J; Merino MJ J Pathol; 2001 Nov; 195(4):429-34. PubMed ID: 11745674 [TBL] [Abstract][Full Text] [Related]
20. Prospective assessment of allelic losses at 4p14-16 in colorectal cancer: two mutational patterns and a locus associated with poorer survival. Arribas R; Ribas M; Risques RA; Masramon L; Tórtola S; Marcuello E; Aiza G; Miró R; Capellà G; Peinado MA Clin Cancer Res; 1999 Nov; 5(11):3454-9. PubMed ID: 10589758 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]